CF PHARMTECH (02652) Included in Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs

Stock News

03/08

CF PHARMTECH (02652) announced that its H shares have been officially included in the list of securities eligible for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs. This adjustment, based on notices issued by the Shanghai Stock Exchange and Shenzhen Stock Exchange, will take effect from March 9, 2026. Starting from the effective date, qualified mainland Chinese investors will be able to trade the company's H shares listed on the Hong Kong Stock Exchange through the Stock Connect mechanisms. The board expects that this inclusion will help broaden the company's shareholder base and enhance the trading liquidity of its H shares.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1192634517"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1192634517\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1192634517?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-08 18:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192634517","market":"sg","top_or_hot":-1,"title":"CF PHARMTECH (02652) Included in Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs","media":"Stock News","content":"<p>CF PHARMTECH (02652) announced that its H shares have been officially included in the list of securities eligible for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs. This adjustment, based on notices issued by the Shanghai Stock Exchange and Shenzhen Stock Exchange, will take effect from March 9, 2026. Starting from the effective date, qualified mainland Chinese investors will be able to trade the company's H shares listed on the Hong Kong Stock Exchange through the Stock Connect mechanisms. The board expects that this inclusion will help broaden the company's shareholder base and enhance the trading liquidity of its H shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PHARMTECH (02652) Included in Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PHARMTECH (02652) Included in Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-08 18:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PHARMTECH (02652) announced that its H shares have been officially included in the list of securities eligible for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs. This adjustment, based on notices issued by the Shanghai Stock Exchange and Shenzhen Stock Exchange, will take effect from March 9, 2026. Starting from the effective date, qualified mainland Chinese investors will be able to trade the company's H shares listed on the Hong Kong Stock Exchange through the Stock Connect mechanisms. The board expects that this inclusion will help broaden the company's shareholder base and enhance the trading liquidity of its H shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1192634517","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192634517","pubTimestamp":1772966656,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CF PHARMTECH (02652) announced that its H shares have been officially included in the list of securities eligible for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs. This...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"161027":"证券","02652":"长风药业","BK1191":"制药","BK4588":"碎股","VT":"世界全股市ETF-Vanguard","BK4585":"ETF&股票定投概念","VXUS":"国际股票ETF-Vanguard"},"translate_title":"CF PHARMTECH(02652)纳入沪港通及深港通计划","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"VXUS":1,"02652":1,"VT":1},"content_text":"CF PHARMTECH (02652) announced that its H shares have been officially included in the list of securities eligible for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs. This adjustment, based on notices issued by the Shanghai Stock Exchange and Shenzhen Stock Exchange, will take effect from March 9, 2026. Starting from the effective date, qualified mainland Chinese investors will be able to trade the company's H shares listed on the Hong Kong Stock Exchange through the Stock Connect mechanisms. The board expects that this inclusion will help broaden the company's shareholder base and enhance the trading liquidity of its H shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}